Anthrocell Company Profile: Valuation & Investors

Anthrocell Overview

Founded
2010

Status
Private

Employees
6

Latest Deal Type
Accelerator/Inc

Investors
1

Anthrocell General Information

Description

Developer of a novel technology designed for the development, production, and manufacture of next-generation pharmaceuticals. The company's platform gives monoclonal antibody products for oncology applications and produce biopharmaceutical proteins, enabling patients to get cured of cancer and age-related diseases.

Contact Information

Website

www.anthrocell.com

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Pharmaceuticals

Primary Office

National Innovation Centre Australian Technology Park 4 Cornwallis Street
Suite G15
Eveleigh, New South Wales 2015
Australia

+61 (02) 0000 0000



Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anthrocell Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Post-Val	Status	Stage
1. Accelerator/Incubator					Completed	Generating Revenue

To view Anthrocell’s complete valuation and funding history, request access »

Anthrocell Executive Team (3)

Name	Title	Board Seat	Contact Info
Galina Kaseko	Co-Founder, Chief Executive Officer & Board Member
Tohsak Mahaworasilpa	Co-Founder, Chief Scientific Officer & Board Member
Eli Tal	Executive Chairman

To view Anthrocell’s complete executive team members history, request access »

Anthrocell Board Members (4)

Name	Representing	Role
Eli Tal	Anthrocell	Executive Chairman
Nicholas Weininger	Anthrocell	Board Member
Suwit Khunkitti Ph.D	Self	Board Member
Tohsak Mahaworasilpa	Anthrocell	Co-Founder, Chief Scientific Officer & Board Member